ABT — Abbott Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Abbott Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,148	10,249	10,170	7,279	7,967
Net Total Accounts Receivable
Net Total Receivables	6,414	6,487	6,218	6,565	6,925
Total Inventory
Prepaid Expenses
Total Current Assets	20,441	24,239	25,224	22,670	23,656
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,130	10,112	10,278	11,276	11,733
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	72,548	75,196	74,438	73,214	81,414
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,907	13,105	15,489	13,841	14,157
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	39,764	39,394	37,752	34,611	33,750
Non Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	32,784	35,802	36,686	38,603	47,664
Total Liabilities & Shareholders' Equity	72,548	75,196	74,438	73,214	81,414
Total Common Shares Outstanding